CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[SBRT Matches Chemoradiation, Preserves QOL Before Pancreatic Surgery]]>

Data ReadoutpositivePositive
AI Analysis

Summary

The SOFT Preop study demonstrated that stereotactic body radiation therapy (SBRT) matched conventional chemoradiation efficacy for preoperative pancreatic adenocarcinoma while preserving patient quality of life. This finding presents an alternative treatment approach for pancreatic cancer patients undergoing surgical resection.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

SBRT matched chemoradiation efficacy while preserving quality of life in preoperative pancreatic adenocarcinoma treatment

Importance:5/10
Sentiment:
0.60
pancreatic cancerSBRTchemoradiationpreoperative treatmentquality of lifeclinical trial

Read the original article

Published by Cancer Network on September 30, 2026 2:00 PM

Read Original